tiprankstipranks
Advertisement
Advertisement
Invivyd completes enrollment of LIBERTY clinical trial
PremiumThe FlyInvivyd completes enrollment of LIBERTY clinical trial
2M ago
Shrader Reiterates Buy on Invivyd, Maintains $10 Price Target on Strong VYD2311 Prospects and High-Risk Population Opportunity
Premium
Ratings
Shrader Reiterates Buy on Invivyd, Maintains $10 Price Target on Strong VYD2311 Prospects and High-Risk Population Opportunity
3M ago
Invivyd completes enrollment in DECLARATION trial
Premium
The Fly
Invivyd completes enrollment in DECLARATION trial
3M ago
Invivyd post earnings selloff overdone, says H.C. Wainwright
PremiumThe FlyInvivyd post earnings selloff overdone, says H.C. Wainwright
4M ago
Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs
Premium
Company Announcements
Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs
4M ago
IVVD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
IVVD Earnings this Week: How Will it Perform?
4M ago
Invivyd announces discovery, advancement of measles antibody candidate VMS063
PremiumThe FlyInvivyd announces discovery, advancement of measles antibody candidate VMS063
5M ago
Invivyd Advances COVID-19 Program and Launches Measles Antibody
Premium
Company Announcements
Invivyd Advances COVID-19 Program and Launches Measles Antibody
5M ago
Invivyd Earnings Call Highlights Pivotal Trial Momentum
Premium
Company Announcements
Invivyd Earnings Call Highlights Pivotal Trial Momentum
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100